| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.31 | 0.05 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |